ATE237352T1 - Helfervirus-freie herstellung von aav - Google Patents

Helfervirus-freie herstellung von aav

Info

Publication number
ATE237352T1
ATE237352T1 AT96918295T AT96918295T ATE237352T1 AT E237352 T1 ATE237352 T1 AT E237352T1 AT 96918295 T AT96918295 T AT 96918295T AT 96918295 T AT96918295 T AT 96918295T AT E237352 T1 ATE237352 T1 AT E237352T1
Authority
AT
Austria
Prior art keywords
helper virus
aav
free production
virus
production
Prior art date
Application number
AT96918295T
Other languages
English (en)
Inventor
Forrest K Ferrari
Xiao Xiao
Richard J Samulski
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE237352T1 publication Critical patent/ATE237352T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96918295T 1995-06-07 1996-06-06 Helfervirus-freie herstellung von aav ATE237352T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48375795A 1995-06-07 1995-06-07
PCT/US1996/009405 WO1996040240A1 (en) 1995-06-07 1996-06-06 Helper virus-free aav production

Publications (1)

Publication Number Publication Date
ATE237352T1 true ATE237352T1 (de) 2003-05-15

Family

ID=23921407

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96918295T ATE237352T1 (de) 1995-06-07 1996-06-06 Helfervirus-freie herstellung von aav

Country Status (7)

Country Link
EP (1) EP0871483B1 (de)
JP (1) JP4108746B2 (de)
AT (1) ATE237352T1 (de)
AU (1) AU707862B2 (de)
CA (1) CA2221293C (de)
DE (1) DE69627532T2 (de)
WO (1) WO1996040240A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2230758A1 (en) * 1995-09-08 1997-03-13 Genzyme Corporation Improved aav vectors for gene therapy
US6004797A (en) 1995-11-09 1999-12-21 Avigen, Inc. Adenovirus helper-free recombinant AAV Virion production
US6221646B1 (en) 1997-07-31 2001-04-24 Chiron Corporation Materials and methods for simplified AAV production
WO1999014354A1 (en) * 1997-09-19 1999-03-25 The Trustees Of The University Of The Pennsylvania Methods and vector constructs useful for production of recombinant aav
ATE286138T1 (de) * 1998-03-20 2005-01-15 Univ Pennsylvania Zusammensetzungen und verfahren zur helfer-freien herstellung von rekombinante adeno-assoziierten viren
US6953690B1 (en) 1998-03-20 2005-10-11 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
EP1124976A1 (de) * 1998-10-27 2001-08-22 Crucell Holland B.V. Verbesserte produktion von aav-vektoren
US6258595B1 (en) * 1999-03-18 2001-07-10 The Trustees Of The University Of Pennsylvania Compositions and methods for helper-free production of recombinant adeno-associated viruses
JP4693244B2 (ja) 1999-03-18 2011-06-01 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア 組換えアデノ随伴ウイルスのヘルパー無しの生産のための組成物および方法
WO2001083797A2 (en) 2000-04-28 2001-11-08 Avigen, Inc. Polynucleotides for use in recombinant adeno-associated virus virion production
KR20150073943A (ko) * 2012-10-03 2015-07-01 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
WO2017077451A1 (en) 2015-11-05 2017-05-11 Bamboo Therapeutics, Inc. Modified friedreich ataxia genes and vectors for gene therapy
CA2971303A1 (en) 2016-06-21 2017-12-21 Bamboo Therapeutics, Inc. Optimized mini-dystrophin genes and expression cassettes and their use
EP3990030A1 (de) 2019-06-27 2022-05-04 Pfizer Inc. Verfahren zur behandlung von duchenne-muskeldystrophie mittels aav-mini-dystrophin-gentherapie
JP2023548816A (ja) 2020-11-03 2023-11-21 ファイザー・インク 陰イオン交換クロマトグラフィーによるａａｖベクターの精製方法
CA3205924A1 (en) 2020-12-23 2022-06-30 Pfizer Inc. Methods for purification of aav vectors by affinity chromatography
US11760788B2 (en) 2021-03-02 2023-09-19 Pathways Neuro Pharma, Inc. Neuroreceptor compositions and methods of use
EP4329820A1 (de) 2021-04-26 2024-03-06 Alexion Pharma International Operations Limited Adeno-assoziierte virale vektorkapside mit verbessertem gewebetropismus
CN113308492B (zh) * 2021-05-31 2023-03-21 北京中因科技有限公司 一种用于复制性aav的检测方法
WO2023114816A1 (en) 2021-12-14 2023-06-22 Neurogene, Inc. Recombinant optimized galc constructs and methods for treating galc-associated disorders
GB202201242D0 (en) 2022-01-31 2022-03-16 Univ Edinburgh Recombinant optimized mecp2 cassettes and methods for treating rett syndrome and related disorders
GB202206336D0 (en) 2022-04-29 2022-06-15 Univ Edinburgh Recombinant therapeutic FMR1 constructs and methods of treating fragile X syndrome and related disorders
WO2024003687A1 (en) 2022-06-28 2024-01-04 Pfizer Inc. Nucleic acids encoding acid alpha-glucosidase (gaa) and vectors for gene therapy
WO2024038365A1 (en) 2022-08-16 2024-02-22 Pfizer Inc. Methods for purification of aav vectors by anion exchange chromatography
WO2025090427A1 (en) 2023-10-23 2025-05-01 University Of Rochester Glial-targeted relief of hyperexcitability in neurodegenerative diseases
WO2025250457A1 (en) 2024-05-28 2025-12-04 University Of Rochester Enhanced brain transduction by gene therapeutics
WO2026017965A1 (en) 2024-07-19 2026-01-22 The University Court Of The University Of Edinburgh Recombinant therapeutic fxn constructs and methods of treating friedreich ataxia and related conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436146A (en) * 1989-09-07 1995-07-25 The Trustees Of Princeton University Helper-free stocks of recombinant adeno-associated virus vectors
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
JP3866760B2 (ja) * 1993-02-22 2007-01-10 ザ ロックフェラー ユニバーシティ 一過性トランスフェクションによる高力価のヘルパーフリーのレトロウイルスの生産

Also Published As

Publication number Publication date
EP0871483A4 (de) 2000-01-05
DE69627532D1 (de) 2003-05-22
DE69627532T2 (de) 2004-01-29
EP0871483A1 (de) 1998-10-21
EP0871483B1 (de) 2003-04-16
AU707862B2 (en) 1999-07-22
CA2221293A1 (en) 1996-12-19
CA2221293C (en) 2012-09-18
JP4108746B2 (ja) 2008-06-25
JPH11510371A (ja) 1999-09-14
WO1996040240A1 (en) 1996-12-19
AU6098596A (en) 1996-12-30

Similar Documents

Publication Publication Date Title
ATE237352T1 (de) Helfervirus-freie herstellung von aav
DE3786592D1 (de) Transformation von trichoderma.
FI951138A7 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
ATE328068T1 (de) Papillomavirus vakzine
DE69332345D1 (de) Herstellung von Brillenlinsen
ATE317908T1 (de) Verfahren zur herstellung von rekombinanten viren
ES2035920T3 (es) Aerolizacion de agente proteico terapeutico.
FI904827A0 (fi) Kalciumkanalsammansaettningar och -foerfaranden.
DE3788984D1 (de) Verwendung von Prostaglandin-D2-aktiven-Substanzen zur Behandlung von Augen-Hypertension und von Glaukom.
ATE198621T1 (de) Herstellung und verwendung von transgenen mäusen mit fehlender expression von cd28
TR199501134A2 (tr) Memeli ve viral proteinleri asiri ifade edilmesi.
DE69001551D1 (de) Latexfilme von naturkautschuk von modifizierter zugfestigkeit.
DE69434777D1 (de) Verwendung von Relaxin zur Herstellung von therapeutischen Mitteln
DE69013011D1 (de) Bcrf1-proteine als inhibitoren von interferon-g(g).
DE68928061D1 (de) Expression von proteinsüssmitteln in hefe
ATE22010T1 (de) Antipsychotische trans-dihydrolisuride.
DE69400223D1 (de) Verwendung von Textilbehandlungszusammensetzungen
HUP0001184A2 (hu) "Basic Helix-Loop-Helix" (bHLH) családba tartozó polipeptidek és a megfelelő nukleinsav-szekvenciák
DE59401956D1 (de) Verwendung von hydroxynaphthalinen in färbemitteln
PT84602A (de) Verwendung von substituierten n-trichlormethylthiohydantionen in kombination mit bis-(2,4-diamino-s-triazin-6-yl)-oligosulfiden in vulkanisierbaren kautschukmischungen und derartige kautschukmischungen
DE3689175D1 (de) Rekombinante Wirte, deren Herstellung und Verwendung.
SU888095A1 (ru) Регулируемый источник посто нного тока
DE69011565D1 (de) Herstellung von Pre-Kaseinaten und Verwendung.
ATE90969T1 (de) Expression von fremden genen in drosophilazellen.
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties